Literature DB >> 9184834

Regulation of chondroitin sulfate biosynthesis by specific sulfation: acceptor specificity of serum beta-GalNAc transferase revealed by structurally defined oligosaccharides.

H Kitagawa1, K Tsutsumi, M Ujikawa, F Goto, J Tamura, K W Neumann, T Ogawa, K Sugahara.   

Abstract

The relationship between sulfation and polymerization in chondroitin sulfate (CS) biosynthesis has been poorly understood. In this study, we investigated the specificity of bovine serum UDP-GalNAc: CS beta-GalNAc transferase responsible for chain elongation using structurally defined acceptor substrates. They consisted of tetra- and hexasaccharide-serines that were chemically synthesized and various regular oligosaccharides with a GlcA residue at the nonreducing terminus, prepared from chondroitin and CS using testicular hyaluronidase. The enzyme preparation was obtained from fetal bovine serum by means of heparin-Sepharose affinity chromatography. The preparation did not contain the alpha-GalNAc transferase recently demonstrated in fetal bovine serum (Kitagawa et al., J. Biol. Chem., 270, 22190-22195, 1995), that utilizes common acceptor substrates. The beta-GalNAc transferase used as acceptors, two hexasaccharide-serines GlcA beta 1-3GalNAc beta 1-4GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-Ser and GlcA beta 1-3GalNAc(4-sulfate) beta 1-4GlcA beta 1-3Gal (4-sulfate) beta 1-3Gal beta 1-4Xyl beta 1-O-Ser, but neither the monosulfated hexasaccharide-serine GlcA beta 1-3GalNAc(4-sulfate) beta 1-4GlcA beta 1-3Gal beta 1-3Gal beta 1-4Xyl beta 1-O-Ser nor tetrasaccharide-serines with or without a sulfate group at C-4 of the third sugar residue Gal-3 from the reducing end. The results indicated that the sulfate group at the Gal-3 C-4 markedly affected the transfer of GalNAc to the terminal GlcA. In addition, a sulfate group at C-4 of the reducing terminal GalNAc of regular tetrasaccharides remarkably enhanced the GalNAc transfer, suggesting that the enzyme recognizes up to the fourth saccharide residue from the nonreducing end. The level of incorporation into a tetra- or hexasaccharide containing a terminal 2-O-sulfated GlcA residue was significant, whereas there was no apparent incorporation into tetra- or hexasaccharides containing a terminal 3-O-sulfated GlcA or penultimate 4,6-O-disulfated GalNAc residue. These results indicated that sulfation reactions play important roles in chain elongation and termination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184834     DOI: 10.1093/glycob/7.4.531

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  12 in total

1.  Mice deficient in N-acetylgalactosamine 4-sulfate 6-o-sulfotransferase are unable to synthesize chondroitin/dermatan sulfate containing N-acetylgalactosamine 4,6-bissulfate residues and exhibit decreased protease activity in bone marrow-derived mast cells.

Authors:  Shiori Ohtake-Niimi; Sachiko Kondo; Tatsuro Ito; Saori Kakehi; Tadayuki Ohta; Hiroko Habuchi; Koji Kimata; Osami Habuchi
Journal:  J Biol Chem       Date:  2010-05-03       Impact factor: 5.157

2.  Synthesis of sulfated oligosaccharides by cystic fibrosis trachea epithelial cells.

Authors:  J Mendicino; S Sangadala
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

3.  Development of a mouse monoclonal antibody against the chondroitin sulfate-protein linkage region derived from shark cartilage.

Authors:  Chizuru Akatsu; Duriya Fongmoon; Shuji Mizumoto; Jean-Claude Jacquinet; Prachya Kongtawelert; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2010-03-25       Impact factor: 2.916

4.  Involvement of chondroitin sulfate synthase-3 (chondroitin synthase-2) in chondroitin polymerization through its interaction with chondroitin synthase-1 or chondroitin-polymerizing factor.

Authors:  Tomomi Izumikawa; Toru Uyama; Yuka Okuura; Kazuyuki Sugahara; Hiroshi Kitagawa
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

5.  Involvement of human natural killer-1 (HNK-1) sulfotransferase in the biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl tetrasaccharide found in α-thrombomodulin from human urine.

Authors:  Taishi Hashiguchi; Shuji Mizumoto; Yuko Nishimura; Jun-ichi Tamura; Shuhei Yamada; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

6.  Sulphation heterogeneity in the trisaccharide (GalNAcSbeta1, 4GlcAbeta1,3GalNAcS) isolated from the non-reducing terminal of human aggrecan chondroitin sulphate.

Authors:  L A West; P Roughley; F R Nelson; A H Plaas
Journal:  Biochem J       Date:  1999-08-15       Impact factor: 3.857

7.  Chondroitin 4-O-Sulfotransferase Is Indispensable for Sulfation of Chondroitin and Plays an Important Role in Maintaining Normal Life Span and Oxidative Stress Responses in Nematodes.

Authors:  Tomomi Izumikawa; Katsufumi Dejima; Yukiko Watamoto; Kazuko H Nomura; Nanako Kanaki; Marika Rikitake; Mai Tou; Daisuke Murata; Eri Yanagita; Ai Kano; Shohei Mitani; Kazuya Nomura; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

8.  Involvement of the core protein in the first beta-N-acetylgalactosamine transfer to the glycosaminoglycan-protein linkage-region tetrasaccharide and in the subsequent polymerization: the critical determining step for chondroitin sulphate biosynthesis.

Authors:  S Nadanaka; H Kitagawa; F Goto; J Tamura; K W Neumann; T Ogawa; K Sugahara
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

9.  Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.

Authors:  B T Kim; H Kitagawa; J Tamura ; T Saito; M Kusche-Gullberg; U Lindahl; K Sugahara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

10.  Regulation of proteoglycan and hyaluronan synthesis by elevated level of intracellular cyclic adenosine monophosphate in peritubular cells from immature rat testis.

Authors:  B Thiébot; M Langris; P J Bonnamy; J Bocquet
Journal:  Mol Cell Biochem       Date:  1998-10       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.